Practice owners and managers
Evaluate workflow, purchasing, and operating fit.
Flagship platformIn development
CLAIR / Veterinary oral health
Better evidence for canine dental triage.
CLAIR is a saliva-based adjunct in development for use alongside the oral examination. The proposed workflow combines collection, controlled processing on a centrifugal microfluidic disc, and optical readout to support triage and the owner conversation.
Development boundary: CLAIR is not for sale or clinical use. Analytical performance, workflow timing, and clinical utility remain to be established for each panel.
01 / Intended role
Support the examination.
Explain the next step.
A saliva-based adjunct for the conversation about further dental assessment.
CLAIR asks whether a quantitative saliva panel can add useful evidence alongside the awake oral exam. The first planned setting is general veterinary practices with active dental services.
Clinical judgment remains central. CLAIR does not replace indicated dental assessment, probing, or radiographs. A low result must not delay otherwise indicated care.
02 / Proposed workflow
Collect. Process.
Read and interpret.
- 01 / Sample
Collection and validity
Define oral collection and checks for sample quality.
- 02 / Disc
Controlled handling
Develop centrifugal processing, reaction control, and assay timing.
- 03 / Readout
Structured interpretation
Evaluate optical readout alongside the clinical context.
03 / Candidate saliva panel
Measure the signals.
Check the sample.
The combined panel and validity controls are a differentiation hypothesis. Multiplexing alone does not establish disease specificity.
Panel composition, thresholds, and interpretation require analytical and clinical validation. CRP remains a separate research track.
- LDH
- Candidate tissue-activity signal
- MPO
- Inflammatory activity
- Phosphorus + pH
- Oral chemistry context
- Occult blood
- Bleeding signal and potential interference
- Sample validity
- Collection and process controls
04 / Evidence before rollout
Three questions.
Three development gates.
Clinical added value remains unproven. Study size and timing depend on feasibility, a funded protocol, and statistical planning.
- 01
Analytical readiness
Can the panel measure reliably?
Evaluate repeatability, interference, sample recovery, and collection and process controls. Report invalid samples.
- 02
Independent clinical evaluation
Does it add useful evidence?
Compare the awake exam, panel alone, and exam plus panel against a blinded reference assessment using anesthetized probing and dental radiographs. Lock the panel and thresholds before independent validation and include realistic confounders.
- 03
Customer validation
Does it work for the clinic?
Study workflow fit, owner understanding, willingness to pay, support needs, and repeat use with veterinary practices.
05 / Clinic collaboration
Help shape what
fits in practice.
The proposed first partners are general veterinary practices with active dental services.
Discuss clinic participationVeterinarians and technicians
Evaluate collection, interpretation, usability, and training needs.
Dog owners and patients
The intended beneficiaries of clearer oral-health conversations.
Onboarding, interpretation guidance, troubleshooting, and consumable replenishment are proposed support needs. Reader, software, and per-test pricing require validation.
Platform foundation
Engineering experience.
Product-specific proof still ahead.
CLAIR draws on lab-on-disc, assay-development, imaging, kinetic-analysis, motor-control, and cartridge engineering experience. Manufacturing, quality-control, and regulatory and commercialization planning remain part of development.
Explore the scientific foundationIntellectual property filing note
U.S. provisional application 64/126,200 was received August 5, 2026 for Portable Centrifugal Diagnostic Platform with Mobile-Device Optical and Kinetic Assay Analysis. A provisional filing is not an issued patent or a determination of patentability.